Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 2, Number 4—October 1996
News and Notes

A Global Theme Issue: Bibliography of References

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Margaret A. Winker
Author affiliation: Journal of the American Medical Association, Chicago, Illinois, USA

Cite This Article

Emerging and reemerging infections respect no national boundaries; therefore, they were an appropriate topic for the first "global medical theme issue," introduced in January 1996. This global theme issue was conceived by three editors, Linda Hawes Clever, The Western Journal of Medicine, Magne Nylenna, Journal of the NorwegianMedicalAssociation, and George D. Lundberg, JournaloftheAmericanMedicalAssociation, who in 1995 invited the editors of 78 journals worldwide to participate. A year later, 36 journals in 21 countries on six continents published more than 200 articles pertaining to emerging and reemerging global microbial threats (1). The articles addressed topics ranging from factors contributing to increasing antimicrobial resistance to the impact of global warming on infectious disease. While some solutions were suggested, the global issue primarily served as a call to medical communities and people worldwide to identify contributing factors and begin to develop strategies to control emergent infections.

Following this note is a bibliography of articles published by the 36 journals participating in the global theme issue.



  1. Addy  PAK, Esani  RK, Atusheno  SKN. Possible contributing factors to the paucity of yellow fever epidemic in the Ashanti Region of Ghana, West Africa. East Afr Med J. 1996;73:39.PubMedGoogle Scholar
  2. Adlestein  S, McKnight  I, Pethebridge  AM. HIV and intermediate immune deficiency. Med J Aust. 1996;164:10910.PubMedGoogle Scholar
  3. Aita  J, Barrera  L, Reniero  A, Hospital transmission of multidrug resistant Mycobacterium tuberculosis in Rosario Argentina. Medicina (B Aires). 1996;56:4850.PubMedGoogle Scholar
  4. Albrecht  H, Sobottka  I, Emminger  C, Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas non-endemic for Leishmania donovani. Arch Pathol Lab Med. 1996;120:18998.PubMedGoogle Scholar
  5. Altekruse  SF, Swerdlow  DL. The changing epidemiology of foodborne diseases. Am J Med Sci. 1996;311:239. DOIPubMedGoogle Scholar
  6. Aseffa  A, Yohannes  G. Antibiotic sensitivity pattern of prevalent bacterial pathogens in Gondar, Ethiopia. East Afr Med J. 1996;73:6771.PubMedGoogle Scholar
  7. Bakken  JS, Krueth  MT, Wilson-Nordskog  C, Tilden  RL, Asanovich  K, Dumler  JS.Clinical and laboratory characteristics of human granulocytic ehrlichiosis (HGE). JAMA. 1996;275:199205. DOIPubMedGoogle Scholar
  8. Bán  E. Changes in the role of gram-positive bacteria in the infections of immunocompromised patients. LAM 1996;6:pages not available.
  9. Banerjee  G, Ayyagari  A, Prasad  KN, Dhole  TN, Singh  SK. Nosocomial infection due to Enterobacter cloacae in a tertiary care hospital in Northern India. Indian J Med Res. 1996;103:623.PubMedGoogle Scholar
  10. Bánhegyi  D. Current situation of HIV/AIDS in Hungary. LAM 1996;6:pages not available.
  11. Barbour  AG. Does Lyme disease occur in the South? Am J Med Sci. 1996;311:3440. DOIPubMedGoogle Scholar
  12. Barnes  PF, El-Hajj  H, Preston-Martin  S, . Transmission of tuberculosis among the urban homeless. JAMA. 1996;275:3057. DOIPubMedGoogle Scholar
  13. Barton  LL, Jeck  DT, Vaidya  VU. Necrotizing fascitis in children: report of two cases and review of the literature. Arch Pediatr Adolesc Med. 1996;150:1058.PubMedGoogle Scholar
  14. Berkelman  RL, Pinner  RW, Hughes  JM. Addressing emerging microbial threats in the United States. JAMA. 1996;275:3157. DOIPubMedGoogle Scholar
  15. Beyers  AD, Donald  PR, van Helden  PD, Ehlers  MRW, Steyn  L, Mizrahi  V. Tuberculosis research - the way forward. S Afr Med J. 1996;86:303.PubMedGoogle Scholar
  16. Beyers  N, Gie  RP, Zietsman  HL, The use of a geographical information system (GIS) to evaluate the distribution of tuberculosis in a high-incidence community. S Afr Med J. 1996;86:404.PubMedGoogle Scholar
  17. Bhatt  KM, Bhatt  SM, Mirza  NB. Meningococcal meningitis. East Afr Med J. 1996;73:359.PubMedGoogle Scholar
  18. Bifani  P, Plikaytis  BB, Kapur  V, Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family: adverse implications for tuberculosis control in the 21st century. JAMA. 1996;275:4527. DOIPubMedGoogle Scholar
  19. Birrie  H, Balcha  F, Bisuneh  A, Bero  G. Susceptibility of Ethiopian Bulinid snails to Schistosoma haematobium from Somalia. East Afr Med J. 1996;73:767.PubMedGoogle Scholar
  20. Bloch  AB, Simone  PM, McCray  E, Castro  KG. Preventing multidrug-resistant tuberculosis. JAMA. 1996;275:4879. DOIPubMedGoogle Scholar
  21. Borus  P. Rabies: the emergence of a microbial threat. East Afr Med J. 1996;73:324.PubMedGoogle Scholar
  22. Bowden  DS, Moaven  LD, Locarnini  SA. New hepatitis viruses: are there enough letters in the alphabet? Med J Aust. 1996;164:879.PubMedGoogle Scholar
  23. Briem  H, Thorsteinsson  SB, Gudmundsson  S, Erlendsson  K, Löve  A. The epidemiology of AIDS in Iceland. Laeknabladid. 1996;82:2131.PubMedGoogle Scholar
  24. Bronze  MS, Dale  JB. The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci. 1996;311:4154. DOIPubMedGoogle Scholar
  25. Budai  J. The present and the future of vaccination in Hungary. LAM 1996;6:pages not available.
  26. Butler  JC, Peters  CJ. Lessons learned from the hantavirus and other hemorrhagic fever viruses. Am J Med Sci. 1996;311:559. DOIPubMedGoogle Scholar
  27. Cabreros  LJ, Rajendran  R, Drimoussis  A, Brandstetter  RD. Radiographic mimics of pneumonia: pulmonary disorders to consider in differential diagnosis. Postgrad Med. 1996;99:13942, 145, 146.PubMedGoogle Scholar
  28. Cairney  R. Global spread of tuberculosis: worrying trend for Canadian physicians. Can Med Assoc J. 1996;154:2368.
  29. Campbell  CM, Williams  BG. Academic research and HIV/AIDS in South Africa. S Afr Med J. 1996;86:5560.PubMedGoogle Scholar
  30. Carballal  G. Emerging or reemerging virus. [in Spanish]. Medicina (B Aires). 1996;56:97101.PubMedGoogle Scholar
  31. Carr  A, Boyle  MJ. Primary HIV infection. Med J Aust. 1996;164:1056.PubMedGoogle Scholar
  32. Cassiere  H, Rodrigues  JC, Fein  AM. Delayed resolution of pneumonia: when is slow healing too slow? Postgrad Med. 1996;99:1514, 157, 158.PubMedGoogle Scholar
  33. Celentano  DD, Nelson  KE, Suprasert  S, . Risk factors for HIV-1 seroconversion infection among young men in northern Thailand. JAMA. 1996;275:1227. DOIPubMedGoogle Scholar
  34. Chen  B, Tao  S. Arbovirus survey in China in recent ten years. Chin Med J. 1996;109:135.PubMedGoogle Scholar
  35. Chen  D-S. Viral hepatitis in East Asia. J Formos Med Assoc. 1996;95:612.PubMedGoogle Scholar
  36. Chopra  I, Hodgson  J, Metcalf  B, Poste  G. New approaches for the control of infections caused by antibiotic-resistant bacteria: an industrial perspective. JAMA. 1996;275:4013. DOIPubMedGoogle Scholar
  37. Chukwuma  C Sr. Microsporidium in AIDS and HIV-infected patients: a perspective. East Afr Med J. 1996;73:725.PubMedGoogle Scholar
  38. Claus  JJ, Kuijper  EJ, de Gans  J. Listeria-meningitis. [Listeria meningitis.]. Ned Tijdschr Geneeskd. 1996;140:1136.PubMedGoogle Scholar
  39. Clemens  J, Brenner  R, Rao  M, Tafari  N, Lowe  C. Evaluating new vaccines for developing countries: efficacy or effectiveness? JAMA. 1996;275:3907. DOIPubMedGoogle Scholar
  40. Clever  LH. Infectious diseases—getting out of a deep hole. West J Med. 1996;164:17.PubMedGoogle Scholar
  41. Collignon  PJ, Bell  JM; AGAR. Drug resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Med J Aust. 1996;164:647.PubMedGoogle Scholar
  42. Colquhoun  SD. Hepatitis C: a clinical update. Arch Surg. 1996;130:1823.
  43. Cunha  BA. Community-acquired pneumonia: cost-effective antimicrobial therapy. Postgrad Med. 1996;99:109, 110, 113, 114, 117–9, 122.PubMedGoogle Scholar
  44. Cunha  BA, Ortega  AM. Atypical pneumonia: extrapulmonary clues guide the way to diagnosis. Postgrad Med. 1996;99:1238, 131, 132.PubMedGoogle Scholar
  45. Davis  KJ, Fritz  DL, Pitt  ML, Welkos  SL, Worsham  PL, Friedlander  AM. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African Green Monkeys (Cercopithecus aethiops). [February] [:pages not yet available.]. Arch Pathol Lab Med. 1996;:120.
  46. Dawson  JE. Warner Ck, Standaert S, Olson JG. The interface between research and the diagnosis of an emerging tick-borne disease, human ehrlichiosis due to Ehrlichia chaffeensis. Arch Intern Med. 1996;156:13742. DOIPubMedGoogle Scholar
  47. de Quadros  CA, Olivé  JM, Hersh  BS, . Measles elimination in the Americas: evolving strategies. JAMA. 1996;275:2249. DOIPubMedGoogle Scholar
  48. de Kantor  IN, Ritacco  V, Barrera  L. Is multidrug resistant tuberculosis an emerging infection in Buenos Aires? [in Spanish]. Medicina (B Aires). 1996;56:1024.PubMedGoogle Scholar
  49. Dhanda  V, Das  PK, Lal  R, Srinivasan  R, Ramaiah  KD. Spread of lymphatic filariasis and reemergence of leishmaniasis in India. Indian J Med Res. 1996;103:4654.PubMedGoogle Scholar
  50. Doherty  RR. HTLV-1 in Australia and Oceania: long term resident or recent immigrant? Med J Aust. 1996;164:846.PubMedGoogle Scholar
  51. Duodenal ulcer: the helicobacterization of a psychosomatic disease? Isr J Med Sc 1996;(March):pages not yet available.
  52. Dwyer  B. What we should be doing about tuberculosis in Australia. Med J Aust. 1996;164:623.PubMedGoogle Scholar
  53. Eskild  A. The AIDS epidemic in Norway - where did it go? [January] [: pages not yet available.]. Tidsskr Nor Laegeforen. 1996;:116.
  54. Espersen  F. Kampen mod mikroberne - et internationalt anliggende (The fight against the microbial threat - an international issue). Ugeskr Laeger. 1996;158:2512.PubMedGoogle Scholar
  55. Espinol  CH. On the trail of color. JAMA. 1996;275:168. DOIPubMedGoogle Scholar
  56. Fadl Alla  AI, Fahal  AH, Ahmed  ME, Hasson  MA. Pattern of postoperative pyrexia in Khartoum. East Afr Med J. 1996;73:7880.PubMedGoogle Scholar
  57. Fattom  AI, Naso  R. Staphylococcal vaccines: a realistic dream. Ann Med. 1996;28:436. DOIPubMedGoogle Scholar
  58. Feingold  DS, Weinberg  AN. Group A streptococcal (gas) infections: and old adversary reemerging with new tricks. Arch Dermatol. 1996;132:6770. DOIPubMedGoogle Scholar
  59. Feldman  C, Klugman  K. Antibiotic-resistant pneumococcal pneumonia. S Afr Med J. 1996;86:2830.PubMedGoogle Scholar
  60. File  TM, Tan  JS, Plouffe  JF. Community-acquired pneumonia: what's needed for accurate diagnosis. Postgrad Med. 1996;99:958, 100, 102, 105–7.PubMedGoogle Scholar
  61. Fine  MJ, Smith  MA, Carson  CA, . Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:13441. DOIPubMedGoogle Scholar
  62. Fodor  T. Pataki G. Bacteriology to the diagnosis of tuberculosis. LAM 1996;6:pages not available.
  63. Fonn  S. A blood-result turn-around time survey to improve congenital syphilis prevention in a rural area. S Afr Med J. 1996;86:6771.PubMedGoogle Scholar
  64. Frost  GW, Johns  M. Vaccine-preventable childhood diseases in Australia. Med J Aust. 1996;164:61.PubMedGoogle Scholar
  65. Fry  DE. The reemergence of mycobacterial infections. Arch Surg. 1996;130:147.
  66. Galama  JMD. Humane herpesvirussen type 6 en 7, verwekkers van onder meer exanthema subitum. [Human herpesviruses type 6 and 7, causative agents of e.g. exanthem subitum.]. Ned Tijdschr Geneeskd. 1996;140:1248.PubMedGoogle Scholar
  67. Gaston  DA, Zurowski  SM. Arcanobacterium haemolyticum pharyngitis and exanthem: three case reports and literature review. Arch Dermatol. 1996;132:614. DOIPubMedGoogle Scholar
  68. George  V, Jesudason  MV, John  TJ. CAMP test for the identification of Vibrio cholerae 0139. Indian J Med Res. 1996;103:557.PubMedGoogle Scholar
  69. Gilbert  GL. Multidrug-resistant tuberculosis: implications for the future; lesions from the past. Med J Aust. 1996;164:60.PubMedGoogle Scholar
  70. Gilbert  GL. Multidrug-resistant tuberculosis: prevention is better than cure. Med J Aust. 1996;164:1203.
  71. Githure  JI, Ngumbi  PM, Anjili  CO, Animal reservoirs of Leishmaniasis in Marigat, Baringo District, Kenya. East Afr Med J. 1996;73:447.PubMedGoogle Scholar
  72. Glanz  K, Yang  H. Communicating about risk of infectious diseases. JAMA. 1996;275:2536. DOIPubMedGoogle Scholar
  73. Gold  SM, Shott  SR, Myer  CM III. Membranous laryngotracheobronchitis. Arch Pediatr Adolesc Med. 1996;150:978.PubMedGoogle Scholar
  74. Goldman  DA, Weinstein  RA, Wenzel  RP, for the Workshop to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals.Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA. 1996;275:23440. DOIPubMedGoogle Scholar
  75. Golledge  CL, Riley  TV. Natural therapy for infectious diseases. Med J Aust. 1996;164:946.PubMedGoogle Scholar
  76. van Gool  T, Dankert  J. Drie opkomende protozaire infectieziekten in Nederland: Cyclospora-, Dientamoeba- en Microspora-infecties. [Three emerging protozoal infections in the Netherlands: cyclospora, dientamoeba, and microspora infections.]. Ned Tijdschr Geneeskd. 1996;:140.
  77. Grant  CC, Duggan  AK, Santosham  M, DeAngelis  C. Oral prednisone as a risk factor for infections in children with asthma. Arch Pediatr Adolesc Med. 1996;150:5863.PubMedGoogle Scholar
  78. Ath  G, Kristinsson  KG, Gudmundsson  S. Antibiotic use and misuse at the National University Hospital, Iceland. Laeknabladid. 1996;82:3945.PubMedGoogle Scholar
  79. Guðmundsdóttir  BK, Guðmundsdóttir  S, Mangnadóttir  B, Helgason  S. Research in bacterial diseases of salmonid fish. Laeknabladid. 1996;82:727.PubMedGoogle Scholar
  80. Haemophilus influenza infection in Singapore: antimicrobial resistance, serotypes and clinical spectrum. [March] [:pages not yet available.]. Ann Acad Med Singapore. 1996;:25.
  81. van Hattum  J. Hepatitis C, een ontwakende reus. [Hepatitis C, an awakening giant.]. Ned Tijdschr Geneeskd. 1996;140:11924.PubMedGoogle Scholar
  82. Haug  C. Emerging and reemerging serious infections: doctors around the world, unite! [January] [:pages not yet available.]. Tidsskr Nor Laegeforen. 1996;:116.
  83. Hayden  FG, Treanor  JJ, Betts  RF, Lobo  M, Esinhart  JD, Hussey  EK. Safety and efficacy of the neuroaminidase inhibitor GG167 in experimental human influenza. JAMA. 1996;275:2959. DOIPubMedGoogle Scholar
  84. Haynes  BF, Putman  SB, Winberg  JB. Update on the issues of HIV vaccine development. Ann Med. 1996;28:3941. DOIPubMedGoogle Scholar
  85. Heath  CH, Blackmore  TK, Gordon  DL. Emerging resistance in Enterococcus species. Med J Aust. 1996;164:1169.PubMedGoogle Scholar
  86. Heikkinen  T, Ruuskanen  O. New prospects in the prevention of otitis media. Ann Med. 1996;28:2330. DOIPubMedGoogle Scholar
  87. Herndon  RM. Evasion of immulogic defenses and emerging viral threats. Arch Neurol. 1996;53:237.PubMedGoogle Scholar
  88. Hilleman  MR. Cooperation between government and industry in combating a perceived emerging pandemic through vaccination: the 1976 swine influenza example. JAMA. 1996;275:2413. DOIPubMedGoogle Scholar
  89. Hoge  CW, Shlim  DR, Echeverria  P, Rajah  R, Herrmann  JE, Cross  JH. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA. 1996;275:5338. DOIPubMedGoogle Scholar
  90. Hogg  GG, Strachan  JE, Huayi  L, Beaton  SA, Robinson  PM, Taylor  K. Non-toxigenic Corynebacterium diphtheriae biovar gravis: evidence for an invasive clone in a south-eastern Australian community. Med J Aust. 1996;164:725.PubMedGoogle Scholar
  91. Hollister  JM, Laing  P, Mednick  SA. Rhesus incompatibility as a risk factor for schizophrenia in male adults. Arch Gen Psychiatry. 1996;53:1924.PubMedGoogle Scholar
  92. Honan  GM, White  GW, Eisenberg  GM. Spontaneous infectious discitis in adults. Am J Med. 1996;100:859. DOIPubMedGoogle Scholar
  93. Hong  T. Human group B rotavirus: adult diarrhea rotavirus. Chin Med J. 1996;109:112.PubMedGoogle Scholar
  94. Hoogkamp-Korstanje  JAA. Yersiniosis. [Yersiniosis.]. Ned Tijdschr Geneeskd. 1996;140:12830.PubMedGoogle Scholar
  95. Hopewell  PC. Mycobacterium tuberculosisan emerging pathogen? West J Med. 1996;164:335.PubMedGoogle Scholar
  96. Horton  R. The infected metropolis. [pages not yet available.]. Lancet. 1996;:347.
  97. Hsueh  P-R, Chen  H-M, Lu  Y-C, Wu  J-J. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in Southern Taiwan. J Formos Med Assoc. 1996;95:2936.PubMedGoogle Scholar
  98. Hu  DJ, Dondero  TJ, Rayfield  MA, . The emerging genetic diversity of HIV: the importance of global surveillance for diagnostics, research, and prevention. JAMA. 1996;275:2106. DOIPubMedGoogle Scholar
  99. Huang  G, Lin  T. Bacterial L-forms research in China. Chin Med J. 1996;109:1820.PubMedGoogle Scholar
  100. Hughes  JM. Emerging pathogens—an epidemiologist's perspective on the problem and priorities for the future. West J Med. 1996;164:212.PubMedGoogle Scholar
  101. Hung  C-C, Chen  Y-C, Chang  S-C, Luh  KT, Hsieh  W-C. Clinical study of nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc. 1996;95:1928.PubMedGoogle Scholar
  102. Indriðason  ÓS, Kristinsson  KG, Ásmundsson  P, Böðvarsson  M. The incidence of infection associated with peritoneal dialysis. Laeknabladid. 1996;82:539.PubMedGoogle Scholar
  103. Infectious diseases - the old and the new. [March] [:pages not yet available.]. Ann Acad Med Singapore. 1996;:25.
  104. Jaax  NK, Davis  KJ, Geisbert  TJ, Lethal experimental infections of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med. 1996;120:14055.PubMedGoogle Scholar
  105. Jacob John  T. Emerging and reemerging global microbial threats. Natl Med J India. 1996;9:12.PubMedGoogle Scholar
  106. Jankovics  I. The influenza viruses: past, present and future. LAM 1996;6:pages not available.
  107. Jernigan  DB, Cetron  MS, Breiman  RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP): a strategy from the DRSP Working Group. JAMA. 1996;275:2069. DOIPubMedGoogle Scholar
  108. John  TJ. Emerging and reemerging bacterial pathogens in India. Indian J Med Res. 1996;103:418.PubMedGoogle Scholar
  109. John  TJ, Jesudason  MV, Lalitha  MK, Melioidosis in India: tip of the iceberg. Indian J Med Res. 1996;103:645.
  110. Johnson  RT. Emerging viral infections. Arch Neurol. 1996;53:1822.PubMedGoogle Scholar
  111. Johnson  PDR, Veitch  MGK, Leslie  DE, Flood  PE, Hayman  JA. The emergence of Mycobacterium ulcerans infection near Melbourne. Med J Aust. 1996;164:768.PubMedGoogle Scholar
  112. Jones  D. Emergence of antibiotic resistance: role of ophthalmology. Arch Ophthalmol. 1996;114:912.PubMedGoogle Scholar
  113. Jónsdóttir  KE, Hansen  H, Arnórsson  VH, Laxdal  T, Stefánsson  M. Immunization against Haemophilus influenzae type b in Iceland: results after six years use of PRP-D (ProHIBiT®). Laeknabladid. 1996;82:328.PubMedGoogle Scholar
  114. Joyce  T, McGuigan  KG, Elmore-Meegan  M, Conroy  RM. Prevalence of entropathogens in stools of rural Maasai children under five years of age in the Maasailand region of the Kenyan Rift Valley. East Afr Med J. 1996;73:5962.PubMedGoogle Scholar
  115. Joynt  RT. Microbial threats. Arch Neurol. 1996;53:17.PubMedGoogle Scholar
  116. Jupp  PG, Kemp  A. What is the potential for future outbreaks of chikungunya, dengue and yellow fever in southern Africa. S Afr Med J. 1996;86:357.PubMedGoogle Scholar
  117. Kager  PA, Wetsteyn  JCFM. Malaria en geneesmiddelenresistentie. [Malaria and drug resistance.]. Ned Tijdschr Geneeskd. 1996;140:1515.PubMedGoogle Scholar
  118. van de Kar  NCAJ, Heuvelink  AE, de Boer  E, Monnens  LAH. Infecties met verocytotoxine-producerende Escherichia coli en het hemolytisch-uremisch syndroom. [Infections with verotoxinogeneic-producing Escherichia coli and the hemolytic-uremic syndrome.]. Ned Tijdschr Geneeskd. 1996;140:1347.PubMedGoogle Scholar
  119. Kelleher  AD, Orth  D. Early HIV-induced immune deficiency. Med J Aust. 1996;164:1078.PubMedGoogle Scholar
  120. Kent  C. Microbial menaces: long neglected system strains to respond to a rising threat. AMNews. 1996;39:912.
  121. Kent  C. Microbial menaces: new era feared, when common bacteria will kill again. AMNews. 1996;39:912.
  122. Khan  AS. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal Virus. Am J Med. 1996;100:468. DOIPubMedGoogle Scholar
  123. Kilstein  J, Sala  R, Greca  A, Battagliotti  C. Oxygen radicals and HIV infection: can antioxidants be of any use? [in Spanish]. Medicina (B Aires). 1996;56:1057.PubMedGoogle Scholar
  124. King  DE. Bronchodilators and antibiotics in the treatment of acute bronchitis. Arch Fam Med. 1996;:5.
  125. Kolmos  HJ. Antibiotika i almen praksis (Antibiotics in general practice). Ugeskr Laeger. 1996;158:25860.PubMedGoogle Scholar
  126. Kolmos  HJ. Rationel anvendelse af antibiotika på hospital (The rationale for the use of antibiotics in hospitals). Ugeskr Laeger. 1996;158:2557.PubMedGoogle Scholar
  127. Koo  D, Maloney  K, Tauxe  R. Epidemiology of diarrheal disease outbreaks on cruise ships: 1989 - 1993. JAMA. 1996;275:5457. DOIPubMedGoogle Scholar
  128. Koziel  MJ. Immunology of viral hepatitis. Am J Med. 1996;100:98109. DOIPubMedGoogle Scholar
  129. Kristinsson  KG. Epidemiology of penicillin resistant pneumococci. Laeknabladid. 1996;82:919.PubMedGoogle Scholar
  130. Kullberg  BJ, Voss  A. Het veranderend patroon van Candida-infecties: andere soorten en meer resistentie. [The changing pattern of Candida infections.]. Ned Tijdschr Geneeskd. 1996;140:14851.PubMedGoogle Scholar
  131. Lawson  KA. Australian contributions to the study of infectious disease. Med J Aust. 1996;164:1135.PubMedGoogle Scholar
  132. Lederberg  J. Infection emergent. JAMA. 1996;275:2435. DOIPubMedGoogle Scholar
  133. LeDuc  JW. World Health Organization: strategy for emerging infectious diseases. JAMA. 1996;275:31820. DOIPubMedGoogle Scholar
  134. Lee  C-M. NG S-H, Wan Y-L, Tsai C-H. Gastric actinomycosis. J Formos Med Assoc. 1996;95:668.PubMedGoogle Scholar
  135. Lee  T, Esterhuyse  T, Steinberg  M, Schneider  H. Demographic modelling of the HIV/AIDS epidemic on the Soweto population- results and health policy implications. S Afr Med J. 1996;86:603.PubMedGoogle Scholar
  136. Lore  W. Emerging and reemerging global microbial threats. East Afr Med J. 1996;73:12.PubMedGoogle Scholar
  137. Ludwig  E. Changes in antibiotic usage. LAM 1996;6:pages not available.
  138. Mackenzie  JS, Smith  DW. Mosquito-borne viruses and epidemic polyarthritis. Med J Aust. 1996;164:903.PubMedGoogle Scholar
  139. MacLean  JD, Arthur  JR, Ward  BJ, Gyorkos  TW, Curtis  MA, Kokaskin  E. The North American liver fluke: Metorchis conjunctus. Lancet. 1996;347:1548. DOIPubMedGoogle Scholar
  140. Magnason  S, Gudmundsson  S. Stefánsson TSv, Erlendsdóttir H, Baldursdóttir L, Kristinsson KG. Nosocomial infections in the ICU at Landspitalinn: an interim report. Laeknabladid. 1996;82:605.PubMedGoogle Scholar
  141. Mainous  AG III, Zoorob  RJ, Hueston  WJ. Current management of acute bronchitis in ambulatory care: the use of antibiotics and bronchodilators. Arch Fam Med. 1996;:5.
  142. Manders  SM, Heymann  WR, Atillasoy  E, Kleeman  J, Schlievert  PM. Recurrent toxin-mediated perineal eyrhtema. Arch Dermatol. 1996;132:5760. DOIPubMedGoogle Scholar
  143. Marriott  D, McMurchie  M. HIV and advanced immune deficiency. Med J Aust. 1996;164:1112.PubMedGoogle Scholar
  144. Martínez-Vázquez  JM, Cabarcos  A. Present and future of the retroviral therapy. An Med Interna. 1995;13:13.
  145. McClure  HM, Novembre  FJ. Simian immunodeficiency virus variants: threat of new retroviruses. Am J Med Sci. 1996;311:303. DOIPubMedGoogle Scholar
  146. McIntyre  J. HIV/AIDS in South Africa - a relentless progression? S Afr Med J. 1996;86:278.PubMedGoogle Scholar
  147. van der Meer  JWM, Hoogkamp-Korstanje  JAA, Kager  PA, Overbeke  AJPM. Opdujkende pathogenen. [Emerging pathogens.]. Ned Tijdschr Geneeskd. 1996;140:1168.PubMedGoogle Scholar
  148. Meis  JFGM, Neeleman  C. Resistentieproblemen bij Streptococcus pneumoniae. [Resistance problems with Streptococcus pneumoniae.]. Ned Tijdschr Geneeskd. 1996;140:1414.PubMedGoogle Scholar
  149. Mekasha  A, Meharie  S. Outbreak of louse-borne relapsing fever in Jimma, south western Ethiopia. East Afr Med J. 1996;73:548.PubMedGoogle Scholar
  150. Mhalu  FS, Lyamuya  E. Human immunodeficiency virus infection and AIDS in East Africa: challenges and possibilities for prevention and control. East Afr Med J. 1996;73:139.PubMedGoogle Scholar
  151. Möller  AD, Guðmundsson  S, Gunnarsdóttir  K, Jónsson  ÓT. Infections in the intensive care unit in Reykjavik City Hospital. Laeknabladid. 1996;82:4652.PubMedGoogle Scholar
  152. Morcillo  N, Alito  A, Romano  MI, A multidrug resistant tuberculosis outbreak in Buenos Aires: DNA fingerprinting analysis. Medicina (B Aires). 1996;56:457.PubMedGoogle Scholar
  153. Mqoqi  NP, Appleton  CC, Dye  AH. Prevalence and intensity of Schistosoma haematobium urinary schistosomiasis in the Port St Johns district. S Afr Med J. 1996;86:7680.PubMedGoogle Scholar
  154. Mugerwa  RD, Marum  LH, Serwadda  D. Human immunodeficiency virus/AIDS in Uganda. East Afr Med J. 1996;73:206.PubMedGoogle Scholar
  155. Mulhausen  PL, Harrel  LJ, Weinberger  M, Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Administration and community nursing homes. Am J Med. 1996;100:2431. DOIPubMedGoogle Scholar
  156. Mutinga  MJ. Phlebotomine sandflies (Diptera Psychodidae) their importance and some aspects of control. East Afr Med J. 1996;73:489.PubMedGoogle Scholar
  157. Nelson  AM, Sledzik  PS, Mullick  FG. The Army Medical Museum/Armed Forces Institute of Pathology and emerging infections: from camp fevers and diarrhea during the American Civil War in the 1860s to global molecular epidemiology and pathology in the 1990s. Arch Pathol Lab Med. 1996;120:12933.PubMedGoogle Scholar
  158. Nelson  RP, Price  LJ, Halsey  AB, Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification. Arch Pediatr Adolesc Med. 1996;150:405.PubMedGoogle Scholar
  159. Nolte  KB, Simpson  GL, Parrish  RG. Emerging infectious agents and the forensic pathologist: the New Mexico model. Arch Pathol Lab Med. 1996;120:1258.PubMedGoogle Scholar
  160. Olafsson  M, Sigurdsson  JA. Increased antimicrobial resistance in urinary tract infections. Laeknabladid. 1996;82:6670.PubMedGoogle Scholar
  161. Olliaro  P, Cattani  J, Wirth  D. Malaria: the submerged disease. JAMA. 1996;275:2303. DOIPubMedGoogle Scholar
  162. Oloo  AJ, Vulule  JM, Koech  DK. Some emerging issues on the malaria problem in Kenya. East Afr Med J. 1996;73:503.PubMedGoogle Scholar
  163. Osborn  JE. Reemerging pathogens. West J Med. 1996;164:234.PubMedGoogle Scholar
  164. Parisi  MN, Enría  D, Pini  N, Sabattini  M. Retrospective detection of clinical infection caused by hantavirus. Medicina (B Aires). 1996;56:113.
  165. Patz  JA, Epstein  PR, Burke  TA, Balbus  JM. Global climate change and emerging infectious diseases. JAMA. 1996;275:21723. DOIPubMedGoogle Scholar
  166. Peters  CJ. Emerging infections—ebola and other filoviruses. West J Med. 1996;164:368.PubMedGoogle Scholar
  167. Petersen  EA. Emerging infectious diseases. Arch Intern Med. 1996;156:124. DOIPubMedGoogle Scholar
  168. Pilote  L, Tulsky  JP, Zolopa  AR, Hahn  JA, Schecter  GF, Moss  AR. Tuberculosis prophylaxis in the homeless: a trial to improve adherence to referral. Arch Intern Med. 1996;156:1615. DOIPubMedGoogle Scholar
  169. Pinner  RW. Addressing the challenges of emerging infectious diseases. Am J Med Sci. 1996;311:38. DOIPubMedGoogle Scholar
  170. Pinner  RW, Teutsch  SM, Simonsen  L, . Trends in infectious diseases mortality in the United States. JAMA. 1996;275:18993. DOIPubMedGoogle Scholar
  171. Plouffe  JF, Breiman  RF, Facklam  RR. for Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA. 1996;275:1948. DOIPubMedGoogle Scholar
  172. Povinelli  M, Remafedi  G, Tao  G. Trends and predictors of human immunodeficiency virus antibody testing by homosexual and bisexual adolescent males, 1980-1994. Arch Pediatr Adolesc Med. 1996;150:338.PubMedGoogle Scholar
  173. Prabhakar  R. Tuberculosis--the continuing scourge of India. Indian J Med Res. 1996;103:1925.PubMedGoogle Scholar
  174. Prado  V. Emerging infections: a new problem? Rev Med Chil. 1996;124:14.
  175. Pretorius  GS, Sirgel  FA, Schaaf  HS, van Helden  PD, Victor  TC. Rifampicin resistance in Mycobacterium tuberculosis - rapid detection and implications in chemotherapy. S Afr Med J. 1996;86:505.PubMedGoogle Scholar
  176. Quinlan  KP, Hayani  KC. Vitamin A and respiratory syncytial virus infection: serum levels and supplementation trial. Arch Pediatr Adolesc Med. 1996;150:2530.PubMedGoogle Scholar
  177. Rathinamisivakumar  RS, Sureshbabu  L, Natarajaseenivasan  K. Leptospiral antibodies in patients with recurrent ophthalmic involvement. Indian J Med Res. 1996;103:668.PubMedGoogle Scholar
  178. Reichman  L. How to ensure the continual resurgence of tuberculosis. [pages not yet available.]. Lancet. 1996;:347.
  179. Samore  MH, Venkatarami  L, DeGirol  PC, Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100:3240. DOIPubMedGoogle Scholar
  180. Sande  M. The public health risk of emerging and reemerging infections. West J Med. 1996;164:1820.PubMedGoogle Scholar
  181. Sanders  EJ, Tukei  PM. Yellow fever an emerging threat for Kenya and other East African countries. East Afr Med J. 1996;73:102.PubMedGoogle Scholar
  182. Satyanarayana  K, Medappa  N. Emerging and reemerging infections. Indian J Med Res. 1996;103:13.PubMedGoogle Scholar
  183. Schellekens  JFP. Kattekrabziekte en andere infecties met Bartonella-species. [Cat-scratch disease and other infections of the Bartonella species.]. Ned Tijdschr Geneeskd. 1996;140:1447.PubMedGoogle Scholar
  184. Schmitt  ED, Camozzi  S, Vigo  G, Tadini  G. Tinea corporis in an HIV-1 infected patient resembled dermatophyte colonies on Sabouraud's agar. Arch Dermatol. 1996;132:2334. DOIPubMedGoogle Scholar
  185. Schmitt  H-J, von König  CHW, Neiss  A, . Efficacy of an acellular pertussis vaccine in infants after household exposure to pertussis. JAMA. 1996;275:3741. DOIPubMedGoogle Scholar
  186. Schwartz  DA, Bryan  RT. Infectious disease pathology and emerging infections: are we prepared? Arch Pathol Lab Med. 1996;120:11724.PubMedGoogle Scholar
  187. Schwartz  DA, Sobottka  I, Leitch  GJ, Cali  A, Visvesvara  GS. Pathology of microsporidiosis: emerging parasitic infections in patients with AIDS. Arch Pathol Lab Med. 1996;120:17388.PubMedGoogle Scholar
  188. Shah  K, Davis  C, Wilson  J, Parekh  B. Chimeric synthetic peptides as antigens for detection of the antibodies to HIV-1 and HIV-2. East Afr Med J. 1996;73:636.PubMedGoogle Scholar
  189. Sharma  VP. Reemergence of malaria in India. Indian J Med Res. 1996;103:2645.PubMedGoogle Scholar
  190. Sharp  B, le Sueur  D. Malaria control in South Africa - the past, the present and selected implications for the future. S Afr Med J. 1996;86:839.PubMedGoogle Scholar
  191. Somekh  E, Abishai  V, Hanani  M, Gutman  R, Mintz  M. The clinical significance of Pseudomonas aeruginosa isolation from stool of neonates. Arch Pediatr Adolesc Med. 1996;150:1089.PubMedGoogle Scholar
  192. Soni  PN, Tait  DR, Gopaul  W, Sathar  MA, Simjee  AE. Hepatitis C virus infection in chronic liver disease in Natal. S Afr Med J. 1996;86:803.PubMedGoogle Scholar
  193. Speed  BR, Gerrard  MP, Kennett  ML, Carron  MG, Harvey  BM. Viral haemorrhagic fevers - current status, future threats. Med J Aust. 1996;164:7983.PubMedGoogle Scholar
  194. St. Geme  JW III. Progress towards a vaccine for nontypable Haemophilus influenzae. Ann Med. 1996;28:317. DOIPubMedGoogle Scholar
  195. Stanton  BF, Li  X, Galbraith  J, Feigelman  S, Kaljee  L. Sexually transmitted diseases, human immunodeficiency virus, and pregnancy prevention: combined contraceptive practices among urban African-American early adolescents. Arch Pediatr Adolesc Med. 1996;150:1724.PubMedGoogle Scholar
  196. SAtephens DS. Farley MM. Emerging and reemerging microbial threats. Am J Med Sci. 1996;311:12. DOIGoogle Scholar
  197. Stevens  DL. Group A streptococcus—from basic science to clinical disease. West J Med. 1996;164:257.PubMedGoogle Scholar
  198. Stewart  GJ. HIV medicine in the mainstream. Med J Aust. 1996;164:978.PubMedGoogle Scholar
  199. Stewart  GJ, Irvine  SS, Scott  M, Strategies of care in managing HIV. Med J Aust. 1996;164:99104.PubMedGoogle Scholar
  200. Strange  P, Skov  L, Lisby  S, Lovgreen  P. Stahpyloccocal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol. 1996;132:2733. DOIPubMedGoogle Scholar
  201. Straub  I. Epidemiological situation in Hungary: past, present and future. LAM 1996;6:pages not available.
  202. Su  I-J, Huang  L-M, Wu  S-J, Detection and sequence analysis of a new herpesvirus-like agent (KSHV) in AIDS and non-AIDS Kaposi's sarcoma in Taiwan: a comparison with related herpesviruses. J Formos Med Assoc. 1996;95:138.PubMedGoogle Scholar
  203. Subtype B isolates of the human immunodeficiency virus type 1 detected in Australia. [March] [:pages not yet available.]. Ann Acad Med Singapore. 1996;:25.
  204. Susser  E, Neugebauer  R, Hoek  HW, Schizophrenia after prenatal famine: further evidence. Arch Gen Psychiatry. 1996;53:2531.PubMedGoogle Scholar
  205. Szalka  A, Printz  G. Hanta viruses and the pulmonal syndrome caused by hanta virus. LAM 1996;6:pages not available.
  206. Taller  AM, Asher  DM, Pomeroy  KL, Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. Arch Gen Psychiatry. 1996;53:3240.PubMedGoogle Scholar
  207. Tamássy  K. Microbiological diagnosis and complex treatment of gastrobulbar alterations: the role of Helicobacter pylori. LAM 1996;6:pages not available.
  208. Tambi  A, Tambi  T. KuiÓec-TepeÓ N. Prevalence and antibiotic sensitivity pattern variations of bacterial isolates in different settings and different periods of time. Acta Med Croatica 1996;pages not available.
  209. Tappero  JW, Khan  AS, Pinner  RW, . Hantavirus pulmonary syndrome 1993: utility of an emergency, telephone-based national surveillance system. JAMA. 1996;275:398400. DOIPubMedGoogle Scholar
  210. Tenover  FC, McGowan  JE. Reasons for the emergence of antibiotic resistance. Am J Med Sci. 1996;311:916. DOIPubMedGoogle Scholar
  211. Tenover  FC, Hughes  JM. The challenges of emerging infectious diseases: development and spread of multiply resistant bacterial pathogens. JAMA. 1996;275:3004. DOIPubMedGoogle Scholar
  212. Thomas  DL, Gruninger  SE, Siew  C, Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med. 1996;100:415. DOIPubMedGoogle Scholar
  213. Thompson  J. Enterokokken: toename van het aantal infecties en van antibioticumresistentie. [Enterococci: increase of the number of infections and of antimicrobial resistance.]. Ned Tijdschr Geneeskd. 1996;140:1303.PubMedGoogle Scholar
  214. Thornsberry  C. Emerging resistance in clinically important gram positive cocci. West J Med. 1996;164:2832.PubMedGoogle Scholar
  215. Thorsteinsson  SB. Infectious diseases in Iceland: current issues and future challenges. Laeknabladid. 1996;82:67.
  216. Tompkins  LS. Bartonella species infections, including cat-scratch disease, trench fever, and bacillary angiomatosis—what molecular techniques have revealed. West J Med. 1996;164:3941.PubMedGoogle Scholar
  217. Tswana  S, Chetsanga  C, Nyström  L, Moyo  S, Nzara  M, Chieza  L. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe. S Afr Med J. 1996;86:725.PubMedGoogle Scholar
  218. Tukei  PM. The threat of Marburg and Ebola viral haemorrhagic fever in Africa. East Afr Med J. 1996;73:2731.PubMedGoogle Scholar
  219. Turnidge  JD, Nimmo  GR, Francis  G; AGAR. Evolution of resistance in Staphylococcus areus in Australian teaching hospitals. Med J Aust. 1996;164:6871.PubMedGoogle Scholar
  220. Ujhelyi  E. The update of the croup-syndrome. LAM 1996;6:pages not available.
  221. Vandenbroucke-Grauls  CMJE. Meticilline-resistente Staphylococcus epidermidis. [Meticillin-resistant Staphylococcus epidermidis.]. Ned Tijdschr Geneeskd. 1996;140:13841.PubMedGoogle Scholar
  222. Vogel  P, Abplanalp  D, Kell  W, Venezuelan equine encephalitis in BALB/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation. Arch Pathol Lab Med. 1996;120:16472.PubMedGoogle Scholar
  223. Waiyaki  PG. Cholera: its story in Africa with special reference to Kenya and other east African countries. East Afr Med J. 1996;73:403.PubMedGoogle Scholar
  224. Walker  DH, Barbour  AG, Oliver  JH, Emerging bacterial zoonotic and vector-borne diseases: ecologic and epidemiologic factors. JAMA. 1996;275:4639. DOIPubMedGoogle Scholar
  225. Wallace  MR, Sharp  TW, Smoak  B, Malaria among US troops in Somalia. Am J Med. 1996;100:4955. DOIPubMedGoogle Scholar
  226. Wann  S-R, Liu  Y-C, Yen  M-Y, Wang  J-S, Chen  Y-S, Wang  J-H, Endogenous Escherichia coli endophthalmitis. J Formos Med Assoc. 1996;95:5660.PubMedGoogle Scholar
  227. Warren  R, Hauman  J, Beyers  N, Unexpectedly high strain diversity of M tuberculosis in a high incidence community. S Afr Med J. 1996;86:459.PubMedGoogle Scholar
  228. Weissenbacher  M, Cura  E, Segura  E, Serological evidence of human hantavirus infection in Argentina, Bolivia and Uruguay. Medicina (B Aires). 1996;56:1722.PubMedGoogle Scholar
  229. Whitcup  SM. Ocular manifestations of AIDS. JAMA. 1996;275:1424. DOIPubMedGoogle Scholar
  230. Wilkinson  D, de Cock  KM. Tuberculosis control in South Africa - time for a new paradigm? S Afr Med J. 1996;86:335.PubMedGoogle Scholar
  231. Wilkinson  D, Moore  DAJ. HIV-related tuberculosis in South Africa - clinical features and outcome. S Afr Med J. 1996;86:647.PubMedGoogle Scholar
  232. Williamson  H. Treatment of acute bronchitis: there's much work to be done. Arch Fam Med. 1996;:5.
  233. Winker  MA, Flanagin  A. Infectious diseases: a global approach to a global problem. JAMA. 1996;275:2456. DOIPubMedGoogle Scholar
  234. Woelffer  GB, Bradford  WZ, Paz  A, Small  PM. A computer assisted molecular epidemiologic approach for confronting the reemergences of tuberculosis. Am J Med Sci. 1996;311:1722. DOIPubMedGoogle Scholar
  235. Xu  J, Cheng  B, Wu  Y, A new diarrhea pathogen: entero-adherent-invasive-toxigenic Escherichia coli. Chin Med J. 1996;109:167.PubMedGoogle Scholar
  236. Yahav  J, Oderda  G, Diver-Haber  A, Serum pepsinogen I in childhood Helicobacter pylori gastritis: its relation to mucosal peptic activity. Isr J Med Sci. 1996;32:569.PubMedGoogle Scholar
  237. Yao  C, Wang  W-W, Chung  Y-M, Su  Y-L, Liu  C-Y, Chen  Y-MA. Transfusion-transmitted AIDS: report of the first case in Taiwan. J Formos Med Assoc. 1996;95:515.PubMedGoogle Scholar
  238. Young  LHY. Therapy for cytomegalovirus retinitis: still no silver lining. JAMA. 1996;275:14950. DOIPubMedGoogle Scholar
  239. Ytterdahl  T. Tropical diseases: an interview with David Stevenson, MD. [January] [:pages not yet available.]. Tidsskr Nor Laegeforen. 1996;:116.
  240. Zaki  SR, Khan  AS, Goodman , . Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Arch Pathol Lab Med. 1996;120:1349.PubMedGoogle Scholar
  241. Zhu  CM. Comments on some new viruses associated with old diseases in China. Chin Med J. 1996;109:510.PubMedGoogle Scholar


Cite This Article

DOI: 10.3201/eid0204.960422

Table of Contents – Volume 2, Number 4—October 1996

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.